Animal Health Solutions

Works fast 1 Simple once-daily dosing No loading or tapering, avoiding the opportunity for rebound of itch 1 Zenrelia helps dogs achieve clinical remission of itch (PVAS <2). 1 Works over the long term, 1 Zenrelia is a treatment for canine allergic itch with just once-daily dosing from the very start. 1 Zenrelia is indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Help get dogs back to normal with Zenrelia Visit Covetrus.vet/Zenrelia INDICATIONS Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. IMPORTANT SAFETY INFORMATION Read the entire package insert, including the Boxed Warning, before using this drug. For full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia. WARNING: INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Monitor dogs for infections because Zenrelia may increase susceptibility to infections, including adenoviral conditions. The most common adverse reactions were vomiting, diarrhea and lethargy. Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs and concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been tested. For full prescribing information see package insert. 1 Forster S, Boegel A, Despa S, et al. Veterinary Dermatology. 2025; 1–10. Works fast 1 Simple once-daily dosing No loading or tapering, avoiding the opportunity for rebound of itch 1 Zenrelia helps dogs achieve clinical remission of itch (PVAS <2). 1 Works over the long term, 1 Zenrelia is a treatment for canine allergic itch with just once-daily dosing from the very start. 1 Zenrelia is indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Help get dogs back to normal with Zenrelia Visit Covetrus.vet/Zenrelia INDICATIONS Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. IMPORTANT SAFETY INFORMATION Read the entire package insert, including the Boxed Warning, before using this drug. For full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia. WARNING: INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Monitor dogs for infections because Zenrelia may increase susceptibility to infections, including adenoviral conditions. The most common adverse reactions were vomiting, diarrhea and lethargy. Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs and concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been tested. For full prescribing information see package insert. 1 Forster S, Boegel A, Despa S, et al. Veterinary Dermatology. 2025; 1–10. Zenrelia, Elanco and the diagonal bar logo are trademarks of Works fast 1 Simple once-daily dosing No loading or tapering, avoiding the opportunity for rebound of itch 1 Zenrelia helps dogs achieve clinical remission of itch (PVAS <2). 1 Works over the long term, 1 Zenrelia is a treatment for canine allergic itch with just once-daily dosing from the very start. 1 Zenrelia is indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Help get dogs back to normal with Zenrelia Visit Covetrus.vet/Zenrelia INDICATIONS Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. IMPORTANT SAFETY INFORMATION Read the entire package insert, including the Boxed Warning, before using this drug. For full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia. WARNING: INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Monitor dogs for infections because Zenrelia may increase susceptibility to infections, including adenoviral conditions. The most common adverse reactions were vomiting, diarrhea and lethargy. Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs and concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been tested. For full prescribing information see package insert. 1 Forster S, Boegel A, Despa S, et al. Veterinary Dermatology. 2025; 1–10. Zenrelia, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2025 Elanco or its affiliates. PM-US-24-1154(4) Works fast 1 Simple once-daily dosing No loading or tapering, avoiding the opportunity for rebound of itch 1 Zenrelia helps dogs achieve clinical remission of itch (PVAS <2). 1 Works over the long term, 1 Zenrelia is a treatment for canine allergic itch with just once-daily dosing from the very start. 1 Zenrelia is indicated for the control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. Help get dogs back to normal with Zenrelia Visit Covetrus.vet/Zenrelia INDICATIONS Zenrelia is indicated for control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. IMPORTANT SAFETY INFORMATION Read the entire package insert, including the Boxed Warning, before using this drug. For full prescribing information call 1 888 545 5973 or visit www.elancolabels.com/us/zenrelia. WARNING: INADEQUATE IMMUNE RESPONSE TO VACCINES. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. Dogs should be up to date on vaccinations prior to starting Zenrelia. Do not use in dogs less than 12 months old or dogs with a serious infection. Monitor dogs for infections because Zenrelia may increase susceptibility to infections, including adenoviral conditions. The most common adverse reactions were vomiting, diarrhea and lethargy. Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs and concurrent use with glucocorticoids, cyclosporine, or other systemic immunosuppressive agents has not been tested. For full prescribing information see package insert. 1 Forster S, Boegel A, Despa S, et al. Veterinary Dermatology. 2025; 1–10. Zenrelia, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2025 Elanco or its affiliates. PM-US-24-1154(4)

• Cover